RECRUITING Not applicable ClinicalTrials.gov

Detection of Blood in the GI Lumen With HemoPill Acute

Sponsor: Stony Brook University • ClinicalTrials.gov ID: NCT07868068

Registry updated: 2026-10-09

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The goal of this clinical trial is to learn if the HemoPill acute (trial device) can detect the presence of blood in participants suspected of having upper gastrointestinal bleeding. The main question it aims to answer is: -What is the clinical relationship between the HemoPill acute (trial device) and endoscopy (control procedure) in detecting the presence of blood/bleeding in the upper gastrointestinal tract? Participants will: * Swallow the HemoPill acute device one (1) to four (4) hours before their scheduled standard of care endoscopy procedure. * Keep the device receiver close to their body from the time of swallowing until completion of their endoscopy procedure. * Return for a follow-up visit(s) to check for the presence or absence of the HemoPill acute device and to report the occurrence of any adverse or serious adverse events.

Interventions

HemoPill acute (Device)
Participants will ingest the HemoPill acute device one (1) to four (4) hours before their scheduled standard of care endoscopy procedure.

Eligibility criteria

Inclusion Criteria: * Greater than or equal to 22 years of age. * Scheduled for upper endoscopy due to suspicion of upper GI bleed as part of standard of clinical care. * Literate and able to provide written informed consent. Exclusion Criteria: * Less than 22 years of age. * Not undergoing upper endoscopy due to suspicion of upper GI bleed as part of standard of clinical care. * Contraindications to the use of the HemoPill acute including: 1. Known GI obstruction, stricture, or fistula; 2. Dysphagia, Zenker's diverticulum, or other swallowing disorders; 3. Achalasia or other esophageal dysmotility. * Cardiac pacemakers or other implanted electrical device(s). * Circulatory or hemodynamic instability at the discretion/determination of the attending endoscopist and clinical care team. * Pregnant or breastfeeding. * Not literate or unable to provide written informed consent.

Conditions

Upper GI Bleeding

Locations

Stony Brook University — Stony Brook, New York, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment